Lauren N Cooper, MD
Emergency Medicine · Covington
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · St Tammany Emergency Physicians Group LLC · Foucher Emergency Group LLC
Hospitals listed: New Orleans East Hospital · St Tammany Parish Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Cooper’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A154157 · Current
Licensed to practise in California · since 2018 · expires 2027-05-31 · Meharry Medical College School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 125066872Temporary Medical Permit · since 2015 · expires 2018-06-23Specialty on the licence: Emergency MedicineExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- New Orleans East HospitalNew Orleans, LAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPart of LCMC Health System, which runs 11 hospitals78% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- St Tammany Parish HospitalCovington, LAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Saint Tammany Health SystemPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.154, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.155, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.531, Oct 2024 – Sep 2025
See every measure and the patient survey for New Orleans East Hospital
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.48 to 1.49) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 9.5 · 34 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.7 · 189 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.45) · 211 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.49) · 199 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.48 (0.84 to 6.11) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.6 to 4.07) · 32 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.58 (0 to 1.88) · 156 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 47 cases | None | Jul 2023 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 40 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.4 to 17.5) · 41 cases | No different | Jan 2022 – Dec 2024 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 84% |
| Staff "always" explained | 69% |
| Yes, staff "did" give patients this information | 77% |
| Yes, staff "did" give patients information about help after discharge | 73% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 83% |
| Doctors "always" treated them with courtesy and respect | 91% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 85% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 90% |
| "Always" quiet at night | 78% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
See every measure and the patient survey for St Tammany Parish Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.154 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.155 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.531 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.89 (0 to 1.89) · 927 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.74 (0.41 to 1.07) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 178.13 (117.96 to 238.3) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 80 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.6 · 117 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.5 · 373 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 296 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 237 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 3,489 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.06 to 0.46) · 4,986 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 5,125 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (1.2 to 5.5) · 1,183 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.39 (0 to 2.97) · 415 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.55 (1.03 to 4.07) · 1,079 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.5 (0 to 13.03) · 412 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.97 (0.19 to 7.74) · 399 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.15) · 196 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.19 (0 to 0.94) · 4,109 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 31 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.501 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.712 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.3 · 306 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 814 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -14 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -6 · 410 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 16 · 302 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 637 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 35 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 299 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.3 (10.9 to 18.9) · 448 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 586 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,296 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 5 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 92% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 80% |
| Nurses "always" listened carefully | 81% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 68% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 92% |
Original Medicare doctor bills
$39,222
Medicare paid this office $39,222 for 314 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Emergency department visit with high level of medical decision making | 236 | $30,136 | $124 |
| Emergency department visit with moderate level of medical decision making | 72 | $5,950 | $83 |
Who their Medicare patients are
314 Original Medicare patients in 2024. Average age 75 · Under 65 9% · 85 and older 15% · Women 57% · Also on Medicaid 16% · Health risk score 1.98. At or below the middle of the specialty; the typical emergency medicine clinician is at 2.01.
Conditions among them: High blood pressure 75% · Coronary heart disease 47% · Depression 43% · Diabetes 42% · Chronic kidney disease 38% · Heart failure 31% · COPD 28% · Atrial fibrillation 27% · Cancer 18% · Dementia 16% · Stroke 15%.
The office billed $606,882, Medicare allowed $52,772 and paid $39,222; for 347 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 314 | 347 | 75 | 1.98 | $606,882 | $39,222 |
| 2023 | 290 | 313 | 75 | 2.00 | $524,129 | $39,308 |
| 2022 | 272 | 298 | 73 | 1.89 | $445,267 | $39,058 |
| 2021 | 353 | 377 | 73 | 1.94 | $556,959 | $52,026 |
| 2020 | 336 | 491 | 69 | 2.99 | $241,237 | $44,897 |
| 2019 | 123 | 199 | 69 | 2.73 | $64,703 | $16,381 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Emergency department visit with high level of medical decision making | 217 | $30,876 | $137 |
| Emergency department visit with moderate level of medical decision making | 62 | $5,845 | $94 |
2022: 3 services
| Emergency department visit with high level of medical decision making | 168 | $27,878 | $158 |
| Emergency department visit with moderate level of medical decision making | 70 | $6,743 | $96 |
| Emergency department visit with low level of medical decision making | 30 | $1,729 | $58 |
2021: 4 services
| Emergency department visit with high level of medical decision making | 242 | $39,643 | $160 |
| Emergency department visit with moderate level of medical decision making | 69 | $6,936 | $99 |
| Critical care, first 30-74 minutes | 13 | $2,758 | $212 |
| Emergency department visit with low level of medical decision making | 26 | $1,606 | $62 |
2020: 4 services
| Emergency department visit with high level of medical decision making | 214 | $32,303 | $147 |
| Emergency department visit with moderate level of medical decision making | 45 | $4,642 | $99 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 123 | $974 | $7 |
| Emergency department visit with low level of medical decision making | 14 | $697 | $50 |
2019: 2 services
| Emergency department visit with high level of medical decision making | 91 | $12,757 | $136 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 65 | $486 | $7 |
Medicaid work
$189,617 in 2024
Medicaid paid $189,617 for 3,558 billed services this clinician did in 2024, up to 52 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 657 | $75,183 |
| EMERGENCY DEPT VISIT MOD MDM | 717 | $67,237 |
| EMERGENCY DEPT VISIT LOW MDM | 221 | $17,334 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 207 | $11,016 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure) | 115 | $5,433 |
| COMPREHENSIVE METABOLIC PANEL | 471 | $3,332 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 471 | $2,400 |
| Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure) | 75 | $1,759 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 71 | $1,626 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), influenza virus types A and B, and respiratory syncytial virus, multiplex amplified probe technique | 15 | $1,605 |
| URINE PREGNANCY TEST | 173 | $1,223 |
| Injection, ketorolac tromethamine, per 15 mg | 146 | $537 |
| 2024 | 3,558 | 19 | 52 | $189,617 |
| 2023 | 4,359 | 23 | 70 | $208,502 |
| 2022 | 4,524 | 26 | 53 | $242,591 |
| 2021 | 3,931 | 24 | 53 | $215,973 |
| 2020 | 920 | 7 | 34 | $77,095 |
| 2019 | 170 | 2 | 28 | $14,369 |
See the largest Medicaid services in earlier years
2023
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 699 | $84,790 |
| EMERGENCY DEPT VISIT MOD MDM | 808 | $71,381 |
| EMERGENCY DEPT VISIT LOW MDM | 234 | $17,594 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 344 | $14,365 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure) | 114 | $3,006 |
| COMPREHENSIVE METABOLIC PANEL | 466 | $2,978 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 123 | $2,680 |
| Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure) | 164 | $2,252 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 466 | $2,160 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 28 | $1,409 |
| URINE PREGNANCY TEST | 217 | $1,271 |
| Infectious agent detection by nucleic acid (DNA or RNA); influenza virus, for multiple types or sub-types, includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, first 2 types or sub-types | 12 | $862 |
2022
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 636 | $80,249 |
| EMERGENCY DEPT VISIT MOD MDM | 741 | $70,205 |
| EMERGENCY DEPT VISIT LOW MDM | 681 | $42,674 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 249 | $15,549 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 126 | $5,612 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure) | 91 | $4,825 |
| EMERGENCY DEPARTMENT VISIT STRAIGHTFORWARD MDM | 95 | $3,968 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 118 | $3,592 |
| Infectious agent detection by nucleic acid (DNA or RNA); influenza virus, for multiple types or sub-types, includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, first 2 types or sub-types | 48 | $3,217 |
| COMPREHENSIVE METABOLIC PANEL | 408 | $2,932 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 413 | $2,235 |
| Radiologic examination, chest; single view | 57 | $1,311 |
2021
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 618 | $73,287 |
| EMERGENCY DEPT VISIT MOD MDM | 735 | $68,669 |
| EMERGENCY DEPT VISIT LOW MDM | 552 | $37,093 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 201 | $13,217 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 170 | $4,635 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure) | 64 | $3,604 |
| COMPREHENSIVE METABOLIC PANEL | 402 | $2,879 |
| Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure) | 98 | $2,495 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 59 | $2,372 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 395 | $2,076 |
| Infectious agent detection by nucleic acid (DNA or RNA); influenza virus, for multiple types or sub-types, includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, first 2 types or sub-types | 18 | $1,437 |
| URINE PREGNANCY TEST | 169 | $971 |
2020
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 484 | $63,688 |
| EMERGENCY DEPT VISIT MOD MDM | 102 | $10,028 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 257 | $2,374 |
| Service | 12 | $440 |
| COMPREHENSIVE METABOLIC PANEL | 39 | $403 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 14 | $101 |
| Injection, ketorolac tromethamine, per 15 mg | 12 | $60 |
2019
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 111 | $13,889 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 59 | $480 |
Drugs they prescribed that Part D paid
$9,517
Pharmacies billed $9,517 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 17% of their Part D prescriptions (74 of 442) in 2024. Above the middle of the specialty; the typical emergency medicine clinician is at 12%.
413 generic and fewer than 11 brand-name prescriptions · $9,517 in drug cost · 97 antibiotic prescriptions to 87 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Albuterol Sulfate Hfa | 11 | $338 | $31 |
| Cephalexin | 39 | $241 | $6 |
| Naproxen | 37 | $218 | $6 |
| Hydrocodone-Acetaminophen | 37 | $155 | $4 |
| Ondansetron Odt | 27 | $107 | $4 |
See all 9 drugs
| Albuterol Sulfate Hfa | 11 | $338 | $31 |
| Cephalexin | 39 | $241 | $6 |
| Naproxen | 37 | $218 | $6 |
| Hydrocodone-Acetaminophen | 37 | $155 | $4 |
| Ondansetron Odt | 27 | $107 | $4 |
| Cyclobenzaprine | 39 | $105 | $3 |
| Oxycodone-Acetaminophen | 24 | $82 | $3 |
| Prednisone | 29 | $66 | $2 |
| Tramadol | 11 | $16 | $1 |
Year by year
| 2024 | 442 | 257 | 17% (74) | None | $9,517 |
| 2023 | 282 | 172 | 9% (26) | None | $4,049 |
| 2022 | 285 | 183 | 14% (39) | None | $7,576 |
| 2021 | 258 | 170 | 11% (29) | 7% | $3,409 |
| 2020 | 162 | 111 | 11% (17) | None | $4,799 |
| 2019 | 57 | 42 | None | None | $2,487 |
| 2018 | 37 | 25 | None | None | $1,001 |
| 2017 | 61 | 49 | None | None | $637 |
| 2016 | 55 | 40 | None | None | $1,169 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Albuterol Sulfate Hfa | 14 | $357 | $26 |
| Cephalexin | 24 | $164 | $7 |
| Naproxen | 26 | $147 | $6 |
| Ondansetron Odt | 20 | $110 | $5 |
| Cyclobenzaprine | 19 | $49 | $3 |
| Prednisone | 13 | $26 | $2 |
2022: 8 drugs
| Albuterol Sulfate Hfa | 11 | $457 | $42 |
| Cephalexin | 23 | $223 | $10 |
| Hydrocodone-Acetaminophen | 30 | $175 | $6 |
| Ondansetron Odt | 15 | $108 | $7 |
| Methocarbamol | 20 | $106 | $5 |
| Methylprednisolone | 13 | $93 | $7 |
| Naproxen | 13 | $85 | $7 |
| Prednisone | 14 | $47 | $3 |
2021: 6 drugs
| Albuterol Sulfate Hfa | 15 | $513 | $34 |
| Ondansetron Odt | 24 | $171 | $7 |
| Methocarbamol | 18 | $94 | $5 |
| Cephalexin | 21 | $84 | $4 |
| Hydrocodone-Acetaminophen | 19 | $73 | $4 |
| Prednisone | 18 | $60 | $3 |
2020: 3 drugs
| Cephalexin | 16 | $129 | $8 |
| Hydrocodone-Acetaminophen | 12 | $69 | $6 |
| Prednisone | 11 | $45 | $4 |
2019: 1 drug
| Cephalexin | 11 | $84 | $8 |
Money from drug and device companies
$23 in 2025
| 2025 | 1 | 1 | None | $23 |
| 2024 | 2 | 5 | None | $82 |
| 2023 | 1 | 1 | None | $17 |
| 2021 | 2 | 2 | None | $166 |
| 2019 | 1 | 1 | None | $11 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Cardiomems | $23 | 1 payment
|
See the published payment
| Abbott Laboratories | Meals · 2025-10-04 | Cardiomems | $23 |
See earlier years (2024, 2023, 2021, 2019)
2024: $82
| AstraZeneca Pharmaceuticals LP | Airsupra | $64 | 4 payments
|
| Kestra Medical Technology Services | Assure Wcd | $18 | 1 payment
|
2023: $17
| Paratek Pharmaceuticals | Nuzyra | $17 | 1 payment
|
2021: $166
| Inari Medical | Flowtriever Catheter, S | $149 | 1 payment
|
| Amgen | Evenity | $16 | 1 payment
|
2019: $11
| AstraZeneca Pharmaceuticals LP | Bevespi Aerosphere | $11 | 1 payment
|
Professional record
- NPI
- 1760862478
- Licence
- CA 154157, IL 125066872, LA 322023California A154157: Current · expires 2027-05-31Illinois 125066872: Expired
- Group
- St Tammany Emergency Physicians Group LLC · Foucher Emergency Group LLC
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207P00000X (207P00000X)
- Mailing address
- 2311 Lark St, New Orleans, LA, 70122
- NPI first listed
- 2015-06-08
- NPI last updated
- 2022-07-26
- NPI record certified
- 2022-07-26
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5841 S Maryland Ave, Chicago, IL, 60637 · 11234 Anderson St, Loma Linda, CA, 92354 · 341 Galvez St, Stanford, CA, 94305